Quick Answer
Ernexa Therapeutics Inc. reported Long-Term Debt of $532.0 thousand for fiscal year 2020.
Ernexa Therapeutics Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2020 | $532.0K | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2020 | $1.62M | — | +0.0% |
| June 30, 2020 | $1.62M | — | — |
- The most recent figure is from Ernexa Therapeutics Inc.’s fiscal year 2020 report (Form 10-K), filed with the SEC on March 11, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: